(0.31%) 5 115.88 points
(0.30%) 38 355 points
(0.36%) 15 985 points
(-0.98%) $83.03
(5.36%) $2.03
(0.29%) $2 354.10
(0.35%) $27.63
(4.10%) $959.95
(-0.26%) $0.932
(-0.44%) $10.98
(-0.57%) $0.796
(1.66%) $93.40
Live Chart Being Loaded With Signals
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 968.00 |
平均出来高 | 54 566.00 |
時価総額 | 6.42M |
EPS | $0 ( 2024-03-20 ) |
次の収益日 | ( $-1.350 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.160 |
ATR14 | $0.0400 (1.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Zhao Jonathon Zhong | Buy | 0 | Common stock |
2024-03-05 | Zhao Jonathon Zhong | Buy | 0 | Series F Convertible Preferred Stock |
2024-01-18 | Patel Himanshu | Buy | 55 553 | Common Stock |
2024-01-18 | Patel Himanshu | Sell | 24 616 | Common Stock |
2024-01-18 | Soinski Jeffrey M | Buy | 74 071 | Common Stock |
INSIDER POWER |
---|
79.32 |
Last 96 transactions |
Buy: 1 530 711 | Sell: 343 509 |
Avinger Inc 相関
10 最も正の相関 | |
---|---|
MPAA | 0.967 |
CAAS | 0.962 |
SXTC | 0.961 |
INVZ | 0.958 |
NVX | 0.958 |
PLUG | 0.957 |
ARVL | 0.956 |
BPYPN | 0.955 |
USEG | 0.954 |
ARDS | 0.954 |
10 最も負の相関 | |
---|---|
BRIVU | -0.946 |
PPYAU | -0.941 |
TYHT | -0.933 |
RAM | -0.931 |
CPTA | -0.929 |
NVCN | -0.926 |
EVOP | -0.925 |
RPHM | -0.92 |
IMRX | -0.917 |
HSTM | -0.916 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Avinger Inc 財務諸表
Annual | 2023 |
収益: | $7.65M |
総利益: | $2.00M (26.18 %) |
EPS: | $-23.31 |
FY | 2023 |
収益: | $7.65M |
総利益: | $2.00M (26.18 %) |
EPS: | $-23.31 |
FY | 2022 |
収益: | $8.27M |
総利益: | $2.65M (32.08 %) |
EPS: | $-41.83 |
FY | 2021 |
収益: | $10.13M |
総利益: | $3.42M (33.80 %) |
EPS: | $-4.57 |
Financial Reports:
No articles found.
Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。